Novartis CEO Says They Will Have to 'Tackle Rhetoric' in US Healthcare

 Vas Narasimhan, Novartis (NVS) CEO, speaks with Francine Laqcua about the Trump administration and the future of pharmaceuticals on the sidelines of the 2025 World Economic Forum in Davos.

https://www.marketscreener.com/quote/stock/NOVARTIS-AG-9364983/news/Novartis-CEO-Says-They-Will-Have-to-Tackle-Rhetoric-in-US-Healthcare-48827802/